跳到正文
原文
Endpoints News 生物医药· Maggie Fick·· 10 天前AI 评分25

特朗普的药品定价协议迫使企业艰难抉择新药上市

Trump’s drug pricing deals force tough choices on launches

AI 导读

根据特朗普的“最惠国”药品定价政策,承诺该政策的企业在推出新药时面临艰难选择。该政策要求药品价格与国际最优惠价格挂钩,迫使企业调整定价策略。

正文

Com­pa­nies that com­mit­ted to Pres­i­dent Don­ald Trump’s drug pric­ing pol­i­cy now face dif­fi­cult de­ci­sions when launch­ing new med­i­cines.

The “most fa­vored na­tion” (MFN) pric­ing pol­i­cy …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news